BioSpace News Archive

Drug Development

OncoSec Provides Encouraging Clinical Observations Related to Triple Negative Breast Cancer Study

To date, five patients with TNBC have been treated with a single cycle of ImmunoPulse IL-12.

January 18, 2018
·
9 min read
Lexington Completes IRB Submission in Preparation for Clinical Study

Another milestone achieved as the Company moves towards HeartSentry human trials.

January 18, 2018
·
4 min read
Job Trends

Almac Group Announces Further Expansion in Support of Clinical and Commercial Drug Supplies at its European Campus in Dundalk, Ireland Following Successful HPRA Inspections

Almac Group today confirmed the successful completion of HPRA inspections of Almac Clinical Services Ireland and Almac Pharma Services Ireland at its European campus in Dundalk, Ireland.

January 18, 2018
·
3 min read
Business

Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results

In advance of the call on February 8, 2018, Organovo will issue its fiscal third-quarter 2018 earnings press release, which will be available at http://www.organovo.com.

January 18, 2018
·
4 min read
BioMidwest

DiaMedica Letter to Shareholders

The company provides a corporate update. in the letter.

January 18, 2018
·
6 min read
Bio NC

Argos Announces One-for-Twenty Reverse Stock Split

The Board of Directors approved a one-for-twenty reverse split of the Company’s common stock that will take effect today, January 18, 2018 after the close of trading.

January 18, 2018
·
5 min read
Business

Immunovaccine Names Joseph Sullivan, Experienced Global Pharmaceutical and Vaccine Executive, as Senior Vice President, Business Development

Mr. Sullivan brings over 25 years of global pharmaceutical and vaccine experience with Merck & Co, Inc. to his new position at Immunovaccine.

January 18, 2018
·
4 min read
Drug Development

Melinta Therapeutics Announces Initiation of Program for Radezolid in Patients With Bacterial Vaginosis

Radezolid is also being studied by Melinta’s partner in a Phase 2 clinical study for the treatment of mild-to-moderate acne vulgaris.

January 18, 2018
·
7 min read
Business

Sandoz Announces Exclusive Global Collaboration With Biocon on Next-Generation Biosimilars

Both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products, and will have a cost and profit share arrangement globally.

January 18, 2018
·
6 min read
Ossur Hf : Q4/FY 2017 Results - Conference call Tuesday 6 February at 9:00 CET

The conference call will be conducted in English.

January 18, 2018
·
1 min read